Calendar

THE ADVANCES INITIATIVE: New Advances in Headache Diagnosis and Treatment

5:30 PM – 6:00 PM Registration/Dinner
6:00 PM – 8:00 PM Meeting

Marriott St. Louis Grand
800 Washington Avenue
St. Louis, MO 63101
Meeting Room: Hawthorne/Lucas/Flora

PROGRAM FEATURES

• Create your own Personalized Poster
• Interactive, case-based learning environment
• iPads provided to enhance learning experience
• 3D videos and glasses provided for all attendees

FACULTY

Jack D. Schim, MD, FAHS
The Neurology Center of Southern California
Co-director, The Headache Center, Carlsbad
Scripps Memorial Hospital-Encinitas
Assistant Clinical Professor of Neurology UCSD
San Diego, CA

M. Susan Burke, MD, FACP
Clinical Associate Professor of Medicine
Sidney Kimmel Medical College at Thomas Jefferson University
Senior Advisor, Lankenau Medical Associates
Lankenau Medical Center
Wynnewood, PA

TARGET AUDIENCE

This activity is intended for neurologists, headache specialists, PCPs, and other HCPs involved in managing patients with headache and migraine issues.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

• Discuss the prevalence, pathophysiology, epidemiology, and burden of illness associated with migraine.
• Describe the diagnostic approach to primary headache disorders, with an emphasis on migraine and cluster headache, including differential diagnosis from other conditions causing headache.
• Discuss the established acute and preventive therapeutic options for patients with migraine.
• Describe publicly available safety and efficacy findings from recent clinical trials investigating novel therapies for the management of migraine.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 2.0 AMA Category 1 Credit(s)^TM.

Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 2.00 contact hour(s) of continuing nursing education of RNs and APN

Purpose: This program would be beneficial for nurses involved in the care for patients with headache and migraine issues.

Credits: 2.00 ANCC Contact Hour(s)

PHARMACISTS

Amedco is accredited by the Accreditation Council for Pharmacy Education as a provider of  continuing pharmacy education.  Successful completion of this program qualifies for up to 2 contact hours.  Full attendance is required.  No partial contact hours will be awarded for partial attendance. UAN:0453-9999-17-348-L04(K)

ABIM MAINTENANCE OF CERTIFICATION

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 Medical Knowledge and Practice Assessment MOC points and patient safety MOC credit in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Information of physician learners in this activity will be shared with ABIM through PARS.

AAPA CREDIT

This program has been reviewed and is approved for a maximum of 2.00 AAPA Category 1 CME credits by the AAPA Review Panel. PAs should claim only the credit commensurate with the extent of their participation in the activity.

This program was planned in accordance with AAPA CME Standards for Live Programs and for Commercial Support of Live Programs.

AAFP CREDIT

This Live activity, The ADVANCES Initiative: New Advances in Headache Diagnosis and Treatment, from 08/17/2017 – 12/05/2017,has been reviewed and is acceptable for up to 2.00 Elective credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AOA CREDIT

The American Osteopathic Association (AOA) Council on Continuing Medical Education has approved this activity for 2 AOA Category 2-A credits.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event Staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

THE ADVANCES INITIATIVE: New Advances in Headache Diagnosis and Treatment

5:30 PM – 6:00 PM Registration/Dinner
6:00 PM – 8:00 PM Meeting

W Dallas – Victory
2440 Victory Park Ln
Dallas, TX, 75219
Meeting Room: Altitude

PROGRAM FEATURES

• Create your own Personalized Poster
• Interactive, case-based learning environment
• iPads provided to enhance learning experience
• 3D videos and glasses provided for all attendees

FACULTY

Jack D. Schim, MD, FAHS
The Neurology Center of Southern California
Co-director, The Headache Center, Carlsbad
Scripps Memorial Hospital-Encinitas
Assistant Clinical Professor of Neurology UCSD
San Diego, CA

M. Susan Burke, MD, FACP
Clinical Associate Professor of Medicine
Sidney Kimmel Medical College at Thomas Jefferson University
Senior Advisor, Lankenau Medical Associates
Lankenau Medical Center
Wynnewood, PA

TARGET AUDIENCE

This activity is intended for neurologists, headache specialists, PCPs, and other HCPs involved in managing patients with headache and migraine issues.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

• Discuss the prevalence, pathophysiology, epidemiology, and burden of illness associated with migraine.
• Describe the diagnostic approach to primary headache disorders, with an emphasis on migraine and cluster headache, including differential diagnosis from other conditions causing headache.
• Discuss the established acute and preventive therapeutic options for patients with migraine.
• Describe publicly available safety and efficacy findings from recent clinical trials investigating novel therapies for the management of migraine.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 2.0 AMA Category 1 Credit(s)^TM.

Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 2.00 contact hour(s) of continuing nursing education of RNs and APN

Purpose: This program would be beneficial for nurses involved in the care for patients with headache and migraine issues.

Credits: 2.00 ANCC Contact Hour(s)

ABIM MAINTENANCE OF CERTIFICATION

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 Medical Knowledge and Practice Assessment MOC points and patient safety MOC credit in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Information of physician learners in this activity will be shared with ABIM through PARS.

AAPA CREDIT

This program has been reviewed and is approved for a maximum of 2.00 AAPA Category 1 CME credits by the AAPA Review Panel. PAs should claim only the credit commensurate with the extent of their participation in the activity.

This program was planned in accordance with AAPA CME Standards for Live Programs and for Commercial Support of Live Programs.

AAFP CREDIT

This Live activity, The ADVANCES Initiative: New Advances in Headache Diagnosis and Treatment, from 08/17/2017 – 12/05/2017,has been reviewed and is acceptable for up to 2.00 Elective credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AOA CREDIT

The American Osteopathic Association (AOA) Council on Continuing Medical Education has approved this activity for 2 AOA Category 2-A credits.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event Staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

THE ADVANCES INITIATIVE: New Advances in Headache Diagnosis and Treatment

Tuesday, October 10, 2017

5:30 PM – 6:00 PM Registration/Dinner
6:00 PM – 8:00 PM Meeting

Courtyard Philadelphia Downtown
21 North Juniper Street
Philadelphia, PA, 19107
Meeting room: Juniper Ballroom

PROGRAM FEATURES

• Create your own Personalized Poster
• Interactive, case-based learning environment
• iPads provided to enhance learning experience
• 3D videos and glasses provided for all attendees

FACULTY

Stephen D. Silberstein, MD
Professor of Neurology
Director, Jefferson Headache Center
Thomas Jefferson University
Philadelphia, PA

Jack D. Schim, MD, FAHS
The Neurology Center of Southern California
Co-director, The Headache Center, Carlsbad
Scripps Memorial Hospital-Encinitas
Assistant Clinical Professor of Neurology UCSD
San Diego, CA

TARGET AUDIENCE

This activity is intended for neurologists, headache specialists, PCPs, and other HCPs involved in managing patients with headache and migraine issues.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

• Discuss the prevalence, pathophysiology, epidemiology, and burden of illness associated with migraine.
• Describe the diagnostic approach to primary headache disorders, with an emphasis on migraine and cluster headache, including differential diagnosis from other conditions causing headache.
• Discuss the established acute and preventive therapeutic options for patients with migraine.
• Describe publicly available safety and efficacy findings from recent clinical trials investigating novel therapies for the management of migraine.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 2.0 AMA Category 1 Credit(s)^TM.

Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 2.00 contact hour(s) of continuing nursing education of RNs and APN

Purpose: This program would be beneficial for nurses involved in the care for patients with headache and migraine issues.

Credits: 2.00 ANCC Contact Hour(s)

ABIM MAINTENANCE OF CERTIFICATION

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 Medical Knowledge and Practice Assessment MOC points and patient safety MOC credit in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Information of physician learners in this activity will be shared with ABIM through PARS.

AAPA CREDIT

This program has been reviewed and is approved for a maximum of 2.00 AAPA Category 1 CME credits by the AAPA Review Panel. PAs should claim only the credit commensurate with the extent of their participation in the activity.

This program was planned in accordance with AAPA CME Standards for Live Programs and for Commercial Support of Live Programs.

AAFP CREDIT

This Live activity, The ADVANCES Initiative: New Advances in Headache Diagnosis and Treatment, from 08/17/2017 – 12/05/2017,has been reviewed and is acceptable for up to 2.00 Elective credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AOA CREDIT

The American Osteopathic Association (AOA) Council on Continuing Medical Education has approved this activity for 2 AOA Category 2-A credits.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event Staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

THE ADVANCES INITIATIVE: New Advances in Headache Diagnosis and Treatment

5:30 PM – 6:00 PM Registration/Dinner
6:00 PM – 8:00 PM Meeting

Cincinnati Marriott at RiverCenter
10 West RiverCenter Boulevard
Covington, KY, 41011
Meeting Room: Covington III

PROGRAM FEATURES

• Create your own Personalized Poster
• Interactive, case-based learning environment
• iPads provided to enhance learning experience
• 3D videos and glasses provided for all attendees

FACULTY

M. Susan Burke, MD, FACP
Clinical Associate Professor of Medicine
Sidney Kimmel Medical College at Thomas Jefferson University
Senior Advisor, Lankenau Medical Associates
Lankenau Medical Center
Wynnewood, PA

Vincent Martin, MD
Professor of Medicine
Department of Internal Medicine
University of Cincinnati
Director of the Headache and Facial Pain Center
University of Cincinnati Gardner Neuroscience Institute
Cincinnati, OH

TARGET AUDIENCE

This activity is intended for neurologists, headache specialists, PCPs, and other HCPs involved in managing patients with headache and migraine issues.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

• Discuss the prevalence, pathophysiology, epidemiology, and burden of illness associated with migraine.
• Describe the diagnostic approach to primary headache disorders, with an emphasis on migraine and cluster headache, including differential diagnosis from other conditions causing headache.
• Discuss the established acute and preventive therapeutic options for patients with migraine.
• Describe publicly available safety and efficacy findings from recent clinical trials investigating novel therapies for the management of migraine.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 2.0 AMA Category 1 Credit(s)^TM.

Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 2.00 contact hour(s) of continuing nursing education of RNs and APN

Purpose: This program would be beneficial for nurses involved in the care for patients with headache and migraine issues.

Credits: 2.00 ANCC Contact Hour(s)

PHARMACISTS

Amedco is accredited by the Accreditation Council for Pharmacy Education as a provider of  continuing pharmacy education.  Successful completion of this program qualifies for up to 2 contact hours.  Full attendance is required.  No partial contact hours will be awarded for partial attendance. UAN: 0453-9999-17-349-L04(K)

ABIM MAINTENANCE OF CERTIFICATION

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 Medical Knowledge and Practice Assessment MOC points and patient safety MOC credit in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Information of physician learners in this activity will be shared with ABIM through PARS.

AAPA CREDIT

This program has been reviewed and is approved for a maximum of 2.00 AAPA Category 1 CME credits by the AAPA Review Panel. PAs should claim only the credit commensurate with the extent of their participation in the activity.

This program was planned in accordance with AAPA CME Standards for Live Programs and for Commercial Support of Live Programs.

AAFP CREDIT

This Live activity, The ADVANCES Initiative: New Advances in Headache Diagnosis and Treatment, from 08/17/2017 – 12/05/2017,has been reviewed and is acceptable for up to 2.00 Elective credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AOA CREDIT

The American Osteopathic Association (AOA) Council on Continuing Medical Education has approved this activity for 2 AOA Category 2-A credits.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event Staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

Location:

SLU School of Medicine
1402 S. Grand Boulevard
St. Louis, MO 63104
(Schwitalla Hall Lecture Hall 1 for Neurology)

Location: Morgan Conference Center (basement level)

Speaker:

Randolph W. Evans, MD, FAANEvans, MD, FAAN
Clinical Professor
Baylor College of Medicine
General Neurology and Headache Specialist
Houston, TX

THE ADVANCES INITIATIVE: New Advances in Headache Diagnosis and Treatment

7:30 AM – 8:00 AM Registration/Breakfast
8:00 AM – 10:00 AM Meeting

JW Marriott Los Angeles L.A. LIVE
900 West Olympic Boulevard
Los Angeles, CA, 90015
Meeting Room: Plaza II & III

PROGRAM FEATURES

• Create your own Personalized Poster
• Interactive, case-based learning environment
• iPads provided to enhance learning experience
• 3D videos and glasses provided for all attendees

FACULTY

Jack D. Schim, MD, FAHS
The Neurology Center of Southern California
Co-director, The Headache Center, Carlsbad
Scripps Memorial Hospital-Encinitas
Assistant Clinical Professor of Neurology UCSD
San Diego, CA

M. Susan Burke, MD, FACP
Clinical Associate Professor of Medicine
Sidney Kimmel Medical College at Thomas Jefferson University
Senior Advisor, Lankenau Medical Associates
Lankenau Medical Center
Wynnewood, Pennsylvania

TARGET AUDIENCE

This activity is intended for neurologists, headache specialists, PCPs, and other HCPs involved in managing patients with headache and migraine issues.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

• Discuss the prevalence, pathophysiology, epidemiology, and burden of illness associated with migraine.
• Describe the diagnostic approach to primary headache disorders, with an emphasis on migraine and cluster headache, including differential diagnosis from other conditions causing headache.
• Discuss the established acute and preventive therapeutic options for patients with migraine.
• Describe publicly available safety and efficacy findings from recent clinical trials investigating novel therapies for the management of migraine.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 2.0 AMA Category 1 Credit(s)^TM.

Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 2.00 contact hour(s) of continuing nursing education of RNs and APN

Purpose: This program would be beneficial for nurses involved in the care for patients with headache and migraine issues.

Credits: 2.00 ANCC Contact Hour(s)

ABIM MAINTENANCE OF CERTIFICATION

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 Medical Knowledge and Practice Assessment MOC points and patient safety MOC credit in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Information of physician learners in this activity will be shared with ABIM through PARS.

AAPA CREDIT

This program has been reviewed and is approved for a maximum of 2.00 AAPA Category 1 CME credits by the AAPA Review Panel. PAs should claim only the credit commensurate with the extent of their participation in the activity.

This program was planned in accordance with AAPA CME Standards for Live Programs and for Commercial Support of Live Programs.

AAFP CREDIT

This Live activity, The ADVANCES Initiative: New Advances in Headache Diagnosis and Treatment, from 08/17/2017 – 12/05/2017,has been reviewed and is acceptable for up to 2.00 Elective credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AOA CREDIT

The American Osteopathic Association (AOA) Council on Continuing Medical Education has approved this activity for 2 AOA Category 2-A credits.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event Staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

THE ADVANCES INITIATIVE: New Advances in Headache Diagnosis and Treatment

5:30 PM – 6:00 PM Registration/Dinner
6:00 PM – 8:00 PM Meeting

Miami Marriott Biscayne Bay
1633 N Bayshore Drive
Miami, FL, 33132-1215
Meeting Room: Salon F

PROGRAM FEATURES

• Create your own Personalized Poster
• Interactive, case-based learning environment
• iPads provided to enhance learning experience
• 3D videos and glasses provided for all attendees

FACULTY

Jack D. Schim, MD, FAHS
The Neurology Center of Southern California
Co-director, The Headache Center, Carlsbad
Scripps Memorial Hospital-Encinitas
Assistant Clinical Professor of Neurology UCSD
San Diego, CA

Anne H. Calhoun, MD, FAHS
Partner/Co-Founder, Carolina Headache Institute
Professor, Department of Anesthesiology
Professor, Department of Psychiatry
University of North Carolina
Chapel Hill, NC

TARGET AUDIENCE

This activity is intended for neurologists, headache specialists, PCPs, and other HCPs involved in managing patients with headache and migraine issues.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

• Discuss the prevalence, pathophysiology, epidemiology, and burden of illness associated with migraine.
• Describe the diagnostic approach to primary headache disorders, with an emphasis on migraine and cluster headache, including differential diagnosis from other conditions causing headache.
• Discuss the established acute and preventive therapeutic options for patients with migraine.
• Describe publicly available safety and efficacy findings from recent clinical trials investigating novel therapies for the management of migraine.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 2.0 AMA Category 1 Credit(s)^TM.

Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 2.00 contact hour(s) of continuing nursing education of RNs and APN

Purpose: This program would be beneficial for nurses involved in the care for patients with headache and migraine issues.

Credits: 2.00 ANCC Contact Hour(s)

PHARMACISTS

Amedco is accredited by the Accreditation Council for Pharmacy Education as a provider of  continuing pharmacy education.  Successful completion of this program qualifies for up to 2 contact hours.  Full attendance is required.  No partial contact hours will be awarded for partial attendance. UAN: 0453-9999-17-347-L04(K)

ABIM MAINTENANCE OF CERTIFICATION

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 Medical Knowledge and Practice Assessment MOC points and patient safety MOC credit in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Information of physician learners in this activity will be shared with ABIM through PARS.

AAPA CREDIT

This program has been reviewed and is approved for a maximum of 2.00 AAPA Category 1 CME credits by the AAPA Review Panel. PAs should claim only the credit commensurate with the extent of their participation in the activity.

This program was planned in accordance with AAPA CME Standards for Live Programs and for Commercial Support of Live Programs.

AAFP CREDIT

This Live activity, The ADVANCES Initiative: New Advances in Headache Diagnosis and Treatment, from 08/17/2017 – 12/05/2017,has been reviewed and is acceptable for up to 2.00 Elective credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AOA CREDIT

The American Osteopathic Association (AOA) Council on Continuing Medical Education has approved this activity for 2 AOA Category 2-A credits.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event Staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

THE ADVANCES INITIATIVE: New Advances in Headache Diagnosis and Treatment

Saturday, November 11, 2017

7:30 AM – 8:00 AM Registration/Breakfast
8:00 AM – 10:00 AM Meeting

New York Marriott Marquis
1535 Broadway
New York, NY  10036
Meeting Room: Marquis Ballroom (located on the 9th floor)

PROGRAM FEATURES

• Create your own Personalized Poster
• Interactive, case-based learning environment
• iPads provided to enhance learning experience
• 3D videos and glasses provided for all attendees

FACULTY

Anne Calhoun, MD, FASH
Partner/Co-Founder, Carolina Headache Institute
Professor, Department of Anesthesiology
Professor, Department of Psychiatry
University of North Carolina
Chapel Hill, NC

Stewart J. Tepper, MD, FAHS
Professor of Neurology
Geisel School of Medicine at Dartmouth
Hanover, NH

TARGET AUDIENCE

This activity is intended for neurologists, headache specialists, PCPs, and other HCPs involved in managing patients with headache and migraine issues.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

• Discuss the prevalence, pathophysiology, epidemiology, and burden of illness associated with migraine.
• Describe the diagnostic approach to primary headache disorders, with an emphasis on migraine and cluster headache, including differential diagnosis from other conditions causing headache.
• Discuss the established acute and preventive therapeutic options for patients with migraine.
• Describe publicly available safety and efficacy findings from recent clinical trials investigating novel therapies for the management of migraine.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 2.0 AMA Category 1 Credit(s)^TM.

Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 2.00 contact hour(s) of continuing nursing education of RNs and APN

Purpose: This program would be beneficial for nurses involved in the care for patients with headache and migraine issues.

Credits: 2.00 ANCC Contact Hour(s)

ABIM MAINTENANCE OF CERTIFICATION

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 Medical Knowledge and Practice Assessment MOC points and patient safety MOC credit in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Information of physician learners in this activity will be shared with ABIM through PARS.

AAPA CREDIT

This program has been reviewed and is approved for a maximum of 2.00 AAPA Category 1 CME credits by the AAPA Review Panel. PAs should claim only the credit commensurate with the extent of their participation in the activity.

This program was planned in accordance with AAPA CME Standards for Live Programs and for Commercial Support of Live Programs.

AAFP CREDIT

This Live activity, The ADVANCES Initiative: New Advances in Headache Diagnosis and Treatment, from 08/17/2017 – 12/05/2017,has been reviewed and is acceptable for up to 2.00 Elective credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AOA CREDIT

The American Osteopathic Association (AOA) Council on Continuing Medical Education has approved this activity for 2 AOA Category 2-A credits.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event Staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

THE ADVANCES INITIATIVE: New Advances in Headache Diagnosis and Treatment

5:30 PM – 6:00 PM Registration/Dinner
6:00 PM – 8:00 PM Meeting

Atlanta Marriott Marquis
265 Peachtree Center Avenue
Atlanta, GA, 30303
Meeting Room: A601 on the Atrium Level

PROGRAM FEATURES

• Create your own Personalized Poster
• Interactive, case-based learning environment
• iPads provided to enhance learning experience
• 3D videos and glasses provided for all attendees

FACULTY

Jack D. Schim, MD, FAHS
The Neurology Center of Southern California
Co-director, The Headache Center, Carlsbad
Scripps Memorial Hospital-Encinitas
Assistant Clinical Professor of Neurology UCSD
San Diego, CA

Andrew Charles, MD
Director Meyer and Renee Luskin Chair
Migraine and Headache Studies
UCLA Medical Center
Los Angeles, CA

TARGET AUDIENCE

This activity is intended for neurologists, headache specialists, PCPs, and other HCPs involved in managing patients with headache and migraine issues.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

• Discuss the prevalence, pathophysiology, epidemiology, and burden of illness associated with migraine.
• Describe the diagnostic approach to primary headache disorders, with an emphasis on migraine and cluster headache, including differential diagnosis from other conditions causing headache.
• Discuss the established acute and preventive therapeutic options for patients with migraine.
• Describe publicly available safety and efficacy findings from recent clinical trials investigating novel therapies for the management of migraine.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 2.0 AMA Category 1 Credit(s)^TM.

Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 2.00 contact hour(s) of continuing nursing education of RNs and APN

Purpose: This program would be beneficial for nurses involved in the care for patients with headache and migraine issues.

Credits: 2.00 ANCC Contact Hour(s)

PHARMACISTS

Amedco is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. Successful completion of this program qualifies for up to 2 contact hours. Full attendance is required. No partial contact hours will be awarded for partial attendance. UAN: 0453-9999-17-307-L04-(K)

ABIM MAINTENANCE OF CERTIFICATION

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 Medical Knowledge and Practice Assessment MOC points and patient safety MOC credit in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Information of physician learners in this activity will be shared with ABIM through PARS.

AAPA CREDIT

This program has been reviewed and is approved for a maximum of 2.00 AAPA Category 1 CME credits by the AAPA Review Panel. PAs should claim only the credit commensurate with the extent of their participation in the activity.

This program was planned in accordance with AAPA CME Standards for Live Programs and for Commercial Support of Live Programs.

AAFP CREDIT

This Live activity, The ADVANCES Initiative: New Advances in Headache Diagnosis and Treatment, from 08/17/2017 – 12/05/2017,has been reviewed and is acceptable for up to 2.00 Elective credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AOA CREDIT

The American Osteopathic Association (AOA) Council on Continuing Medical Education has approved this activity for 2 AOA Category 2-A credits.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event Staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

THE ADVANCES INITIATIVE: New Advances in Headache Diagnosis and Treatment

5:30 PM – 6:00 PM Registration/Dinner
6:00 PM – 8:00 PM Meeting

Renaissance Nashville Hotel
611 Commerce Street
Nashville, TN, 37203
Meeting Room: Music City Ballroom

PROGRAM FEATURES

• Create your own Personalized Poster
• Interactive, case-based learning environment
• iPads provided to enhance learning experience
• 3D videos and glasses provided for all attendees

FACULTY

Jack D. Schim, MD, FAHS
The Neurology Center of Southern California
Co-director, The Headache Center, Carlsbad
Scripps Memorial Hospital-Encinitas
Assistant Clinical Professor of Neurology UCSD
San Diego, CA

M. Susan Burke, MD, FACP
Clinical Associate Professor of Medicine
Sidney Kimmel Medical College at Thomas Jefferson University
Senior Advisor, Lankenau Medical Associates
Lankenau Medical Center
Philadelphia, PA

TARGET AUDIENCE

This activity is intended for neurologists, headache specialists, PCPs, and other HCPs involved in managing patients with headache and migraine issues.

LEARNING OBJECTIVES

After completing the CME activity, learners should be better able to:

• Discuss the prevalence, pathophysiology, epidemiology, and burden of illness associated with migraine.
• Describe the diagnostic approach to primary headache disorders, with an emphasis on migraine and cluster headache, including differential diagnosis from other conditions causing headache.
• Discuss the established acute and preventive therapeutic options for patients with migraine.
• Describe publicly available safety and efficacy findings from recent clinical trials investigating novel therapies for the management of migraine.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 2.0 AMA Category 1 Credit(s)^TM.

Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Awarded 2.00 contact hour(s) of continuing nursing education of RNs and APN

Purpose: This program would be beneficial for nurses involved in the care for patients with headache and migraine issues.

Credits: 2.00 ANCC Contact Hour(s)

ABIM MAINTENANCE OF CERTIFICATION

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 2 Medical Knowledge and Practice Assessment MOC points and patient safety MOC credit in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Information of physician learners in this activity will be shared with ABIM through PARS.

AAPA CREDIT

This program has been reviewed and is approved for a maximum of 2.00 AAPA Category 1 CME credits by the AAPA Review Panel. PAs should claim only the credit commensurate with the extent of their participation in the activity.

This program was planned in accordance with AAPA CME Standards for Live Programs and for Commercial Support of Live Programs.

AAFP CREDIT

This Live activity, The ADVANCES Initiative: New Advances in Headache Diagnosis and Treatment, from 08/17/2017 – 12/05/2017,has been reviewed and is acceptable for up to 2.00 Elective credit(s) by the American Academy of Family Physicians. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

AOA CREDIT

The American Osteopathic Association (AOA) Council on Continuing Medical Education has approved this activity for 2 AOA Category 2-A credits.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff, and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.
Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event Staff will be glad to assist you with any special needs (i.e. physical, dietary, etc.) Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

A 3D View: Improving Acute Preventive Treatment of Migraine in Primary Care Setting Using Novel Agents

6:00 PM – 6:30 PM Registration/Dinner
6:30 PM – 7:45 PM Meeting

VENUE

PROGRAM FEATURES

• 1.15 CME Credits: A 3D View!
• 3D Glasses Provided to all attendees
• Interactive, case-based learning environment
• Create your own Personalized Poster

REGISTRATION INFORMATION

To register for the live event meeting or simulcast, please visit www.MLG-Migraine.com or call 2017-406-4248.

FACULTY

Anne H. Calhoun, MD, FAHS
Partner/Co-Founder, Carolina Headache Institute
Professor, Department of Anesthesiology
Professor, Department of Psychiatry
University of North Carolina
Chapel Hill, NC

Andrew Charles, MD
Professor of Neurology
Director, UCLA Goldberg Migraine Program
Meyer and Renee Luskin Chair in Migraine and Headache Studies
David Geffen School of Medicine at
University of California,
Los Angeles, LA

AGENDA

I. Migraine: Overview

• The burden of migraine: epidemiology, disability and quality of life, economic burden
• Migraine pathophysiology
• Migraine and other primary headaches: classification and diagnosis
• Challenges of differential diagnosis

II. The Current Challenges and Needs in Migraine Management

• Expanding role for primary care providers and doctors of osteopathy
• Evidence-based approach to acute and preventive treatment of migraine
• Abortive agents in development: lasmiditan, gepants, new delivery devices for existing agents
• Migraine prevention: what are the current unmet needs?
• Patient segmentation: identifying the patients with refractory chronic migraine

Patient video showing the process of differential diagnosis – leading in to treatment

III. Targeting CGRP or Its Receptor: A New Era in Targeting Migraine Underlying Pathology

• Role of CGRP in the trigeminovascular system and in migraine
  • Mechanism of action of gepants and mAbs to CGRP or its receptor
• Update of recently released data from clinical trials
• Safety
• Patient-reported outcomes
• Adherence, persistence and cost-effectiveness, impact on access
• Interactive case studies, including refractory chronic migraine cases

IV. Neuromodulation: A Brief Update

V. Clinician-patient Communication: Case-based Discussion

• Improving patient/physician and physician/physician communication

VI. “Conclusions and Questions & Answers

EDUCATIONAL OBJECTIVES

• Review best practices for diagnosing migraine headaches including the process of differential diagnosis
• Assess efficacy and safety profiles of investigational agents for the acute treatment of migraine, as well as calcitonin-gene related peptide (CGRP)-targeting agents for the prevention of episodic and chronic migraine
• Describe burdens associated with migraine headaches and the use of patient reported outcomes for measuring the impact of new and established migraine therapies
• Discuss strategies for managing migraine that include the integration of novel treatment options and the application of methods for

TARGET AUDIENCE

This activity is intended for primary care providers and doctors of osteopathy working with patients with migraine headaches.

ACCREDITATION STATEMENT

Med Learning Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. This CME activity was planned and produced in accordance with the ACCME Essentials.

CREDIT DESIGNATION STATEMENT

Med Learning Group designates this live activity for a maximum of 1.15 AMA Category 1 Credit^TM. Physicians should claim only the credit commensurate with the extent of their participation in the live activity.

NURSING CREDIT INFORMATION

Purpose: This program would be beneficial for nurses involved in treating and managing patients with migraine. CNE Credits: 1.15 ANCC Contact Hours

CNE Accreditation Statement

Ultimate Medical Academy/CCM is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation.

ABIM MAINTENANCE OF CERTIFICATION

Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 1.15 MOC in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

AOA CREDIT

Med Learning Group will apply to the American Osteopathic Association (AOA) Council on Continuing Medical Education to approve this symposium for AOA Category 2-A credits.

DISCLOSURE POLICY STATEMENT

In accordance with the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, educational programs sponsored by Med Learning Group must demonstrate balance, independence, objectivity, and scientific rigor. All faculty, authors, editors, staff and planning committee members participating in a MLG-sponsored activity are required to disclose any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) and/or provider(s) of commercial services that are discussed in an educational activity.

DISCLOSURE OF UNLABELED USE

Med Learning Group requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States.

DISCLAIMER

Med Learning Group makes every effort to develop CME activities that are scientifically based. This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development in an effort to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

For CME questions, please contact Med Learning Group at info@medlearninggroup.com.

Contact this CME provider at Med Learning Group for privacy and confidentiality policy statement information at www.medlearninggroup.com/privacy-policy/

AMERICANS WITH DISABILITIES ACT

Event staff will be glad to assist you with any special needs (eg, physical, dietary, etc.). Please contact Med Learning Group prior to the live event at info@medlearninggroup.com

A 3D View: Improving Acute Preventive Treatment of Migraine in Primary Care Setting Using Novel Agents

5:30 PM – 6:00 PM Registration / Dinner
6:00 PM – 7:30 PM Meeting

VENUE

A 3D View: Improving Acute Preventive Treatment of Migraine in Primary Care Setting Using Novel Agents

5:30 PM – 6:00 PM Registration / Dinner
6:00 PM – 7:30 PM Meeting

VENUE